Football Association of Wales (FAW) chief executive Noel Mooney has revealed the "legacy" role of Wrexham owners Ryan ...

Ryan Reynolds and Rob McElhenney have never been shy about big dreams for Wrexham. From Hollywood screens to the oldest ...

Ryan Reynolds and Rob McElhenney's ambitious plans for Wrexham's SToK Cae Ras home could see World Cup 2035 games played at ...

Phil Parkinson's side are aiming to sign a 27-year-old from Bournemouth, while they are also keen on Liverpool, Cardiff and ...

George Dobson is bidding to learn from midfield partner Lewis O'Brien following the summer signing's impressive start to life ...

Wrexham smashed its club record for a transfer fee in announcing the signing of Nathan Broadhead from Ipswich Town on ...

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $24.5, a high estimate of $30.00, and a low estimate of $22.00. This upward trend is apparent, ...

Analysts have given Stoke Therapeutics a total of 3 ratings, with the consensus rating being Buy. The average one-year price target is $29.0, indicating a potential 121.37% upside.

Ryan Reynolds and Rob McElhenney have overseen a record-breaking window at Wrexham, but the hope is for “more transfer activity”.

Funeral details have been confirmed for the life of Wrexham AFC football legend Joey Jones.

The market expects Stoke Therapeutics, Inc. (STOK) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended June 2025. This widely-known ...

Ryan Reynolds & Rob McElhenney preparing for the big time? Wrexham submit plans for even more seats in new Kop Stand at SToK Cae Ras ...